[1] |
TANG Duocai, ZHOU Shukui, ZHANG Guiyin, LIU Lei, LIAO Hong.
Analysis of risk factors of recurrence in non-muscle invasive bladder cancer patients after initial transurethral resection of bladder tumor
[J]. China Oncology, 2023, 33(5): 478-483.
|
[2] |
CAO Mengxuan, HU Can, ZHANG Yanqiang, HUANG Ling, DU Yian, YU Pengcheng, ZHANG Ruolan, XU Zhiyuan, CHENG Xiangdong.
Analysis of risk factors of early recurrence and metastasis after radical resection of gastric cancer
[J]. China Oncology, 2022, 32(7): 588-595.
|
[3] |
LIU Jiawei, LI Dan, ZHAI Qing.
Risk factors analysis of liver injury induced by chemotherapy in patients with breast cancer
[J]. China Oncology, 2021, 31(1): 52-62.
|
[4] |
LIU Qian , QIAO Meng , MAO Shiqi , YANG Shuo , LIU Yiwei , ZHAO Chao , LI Xuefei , REN Shengxiang , ZHOU Caicun .
Impact of metastatic organ on prognosis in extensive-stage small cell lung cancer
[J]. China Oncology, 2021, 31(1): 45-51.
|
[5] |
DING Pingan, YANG Peigang, TIAN Yuan, GUO Ziyang, GUO Honghai, LIU Yang, ZHANG Zhidong, WANG Dong, LI Yong, ZHAO Qun.
Effect of extranodal invasion on survival and prognosis of gastric cancer patients: a report of 2 386 cases
[J]. China Oncology, 2020, 30(12): 1017-1025.
|
[6] |
MA Xiaokai,HUANG Jiankang,ZHU Bo,PENG Defeng,ZHOU Rui,WANG Shengying .
Clinical characteristics of papillary thyroid microcarcinoma and risk factors for cervical lymph node metastasis: a clinical analysis of 228 cases
[J]. China Oncology, 2019, 29(8): 590-594.
|
[7] |
MIAO Changfeng,MA Yuntao,WANG Xiaopeng,HU Ming,YANG Xiaojun .
Construction of the risk factor model of gastric cancer and its value in screening opportunity and options
[J]. China Oncology, 2019, 29(7): 501-507.
|
[8] |
LIU Shan, FANG Juan, WANG Lili, ZHANG Yinghong, DU Wenjie, ZHU Taohua.
Association between peripheral nerve invasion and recurrence risk factors in cervical cancer
[J]. China Oncology, 2019, 29(6): 439-444.
|
[9] |
GU Xiaoli, CHENG Wenwu, CHEN Menglei, et al.
The characteristics of Traditional Chinese Medicine syndrome and its relationship with survival time among patients with advanced cancer
[J]. China Oncology, 2018, 28(7): 532-537.
|
[10] |
LI Ling, MA Guixia, SI Zhuangli, et al.
Clinical study on treating cancer-related nausea, vomiting and fatigue using metoclopramide plus haloperidol
[J]. China Oncology, 2018, 28(5): 394-400.
|
[11] |
LIU Xiaoxue, YU Chuanhua, ZHOU Wei, et al.
Trends in colorectal cancer mortality for the last 30 years in China
[J]. China Oncology, 2018, 28(3): 177-183.
|
[12] |
LIN Xuedan, YANG Tianxing,TAO Zhihua.
Predictive value of CEA and CA19-9 for recurrence in stage Ⅱ-Ⅲ colon cancer
[J]. China Oncology, 2018, 28(11): 827-832.
|
[13] |
SHEN Lihua, ZHANG Zhongwei, ZHU Biao.
Clinical analysis of tumor related venous thromboembolism: 196 cases
[J]. China Oncology, 2016, 26(4): 338-345.
|
[14] |
DONG Fen, ZHANG Biao, SHAN Guangliang.
Distribution and risk factors of thyroid cancer in China
[J]. China Oncology, 2016, 26(1): 47-52.
|
[15] |
GU Xiaoli, CHENG Menglei, LIU Minghui, et al.
Management of malignant asictes in terminally ill cancer patients
[J]. China Oncology, 2015, 25(12): 994-998.
|